Introduction 27 Israeli acute paralysis virus (IAPV), Acute bee paralysis virus (ABPV) and Kashmir bee virus 28 (KBV) constitute a complex of genetically and biologically closely related viruses (de 29
For the 1st series of experiments, we collected five to eight days-old workers, from 78 which four whole body samples were prepared and three samples of each body part (head, gut 79 and remnants; separated under a binocular microscope). For the 2nd series of experiments, we 80 produced an IAPV inoculum by propagating an IAPV reference isolate (Allen and Ball, 1995) 81 in 50 white-eyed honeybee pupae and preparing a chloroform-clarified extract in 10 mM 82 phosphate buffer (pH 7.0)/0.02% diethyl dithiocarbamate (de Miranda et al., 2013) . This 83 IAPV inoculum had <0.1% contamination with other common honeybee viruses, as 84 determined by RT-qPCR using previously published assays for IAPV, ABPV, KBV, Chronic 85 bee paralysis virus, Deformed wing virus, Varroa destructor virus-1, Slow bee paralysis virus, 86
Sacbrood virus and Black queen cell virus (Locke et al., 2012). The primers for the above 87 assay are also attached in Supplementary material. The identity of the reference isolate and 88 propagated inoculum was confirmed by sequencing the IAPV PCR product. The exact IAPV 89 particle concentration was determined using transmission electron microscopy, and an IAPV 90 stock inoculum containing 1x10 6 IAPV particles per µl was prepared. This was diluted to 10 91 particles per µl for inoculation experiments. Five to eight days-old workers were injected with 92 2 µl IAPV inoculation solution (20 IAPV particles), or 2 µl of control solution (10 mM 93 phosphate buffer (pH 7.0)/0.02% diethyl dithiocarbamate). Afterwards, four individuals were 94 collected for the IAPV-injected or control samples at each time moment of 8, 24, 48 and 72 h. 95 RNA was extracted from each sample using the RNeasy mini kit (Qiagen, Germany) 96 and remaining DNA was removed by using TURBO DNA-free TM kit (Ambion, USA). RNA 97 concentration and purity were determined using spectrophotometry (260 nm) 
Results and Discussion 120
For the 1st series of experiments, the M values calculated by GeNorm PLUS were less than 0.5 121 for all of the five candidate reference genes in whole bodies, guts and remnants, while in the 122 heads the M values of three of the candidate genes (RPL23, UBI and ELF1α) were less than 123 0.5 (Table 1) . When analyzing RT-PCR data from all the samples in 1st series together, all 124 reference genes had an M value higher than 0.5 and ranked from the most stable (lowest M 125 value) to the least stable (highest M value) as: PPIA<TBP<RPL23<UBI<ELF1α (Table 1) . 126
For the 2nd series of experiments, concerning the virus-infection time course, we analyzed the 127 stability of the reference genes at 8, 24, 48, 72 h after injecting the bumblebees with IAPV. 128
The IAPV transcript levels in the 8 h and 24 h post-inoculation samples were below the 129 detection limit of RT-PCR and comprised the "low IAPV" samples, while the 48 h and 72 h 130 post-inoculation samples comprised the "high IAPV" samples ( Fig. 1A -IAPV inoculation) . 131
The IAPV detection limit (1x10 5 particles/bee) was determined by spiking a virus-free 132 bumblebee extract with 1×10 7 IAPV particles, purifying the RNA and preparing a ten-fold 133 serial dilution of the RNA prior to RT-PCR (Fig. 1A -IAPV particles) . This detection limit 134 corresponds to ~2 IAPV cDNA molecules per PCR reaction (i.e. close to the theoretical 135 detection limit of PCR), after accounting for the different dilution factors associated with 136 RNA extraction, DNAse treatment, cDNA synthesis and PCR. As shown in Table 1 The results from the data analysis using GeNorm PLUS were compared with those obtained 146 using NormFinder, an alternative program for analyzing the stability of potential internal 147 reference genes. The rankings of the five candidate internal reference genes for individual 148 body parts (1 st series) and individual post-inoculation time points (2 nd series) slightly differ 149 between the two analyses except the whole body group (Table 1) . This in itself is not8 identify PPIA and RPL23 as the best two internal reference genes for IAPV infection studies 152 in bumblebees and these are also among the top three genes identified by both algorithms for 153 body parts-specific studies. One remarkable observation for the body parts-specific studies 154
(1 st series) was the stability values were (with a few exceptions) well below 0.5 for individual 155 tissues or whole body extracts, but above 0.5 when the data was pooled into a single analysis 156 indicated by GeNorm gene expression analysis when grouping the data from various body parts and whole body 165 extracts together. We also calculated the V n / n+1 for all samples of the 2 nd series, where 166 bumblebees were analyzed at different time intervals after IAPV infection. The combined data 167 of all IAPV-infected and control samples suggested that just three internal reference genes 168 (PPIA, RPL23 and UBI) were sufficient to normalize the data for all samples and that 169 including a fourth reference gene would not improve normalization. 170
In conclusion, PPIA was the single most optimal internal reference gene for IAPV 171 infection studies in bumblebees, due to its good stability at individual time intervals after 172 virus infection, as well as for all time intervals combined, while the PPIA-RPL23-UBI 173 combination was optimal and fully sufficient for normalization of IAPV infection experiments 174 when using multiple reference genes. 175
To our knowledge, this is the first report of the validation of reference genes with9 respect to virus infections in bumblebees and pollinating insects. We only validated the five 177 candidate internal reference genes for whole-body extracts of IAPV-infected samples. The 178 results from the 1 st series, on uninfected body parts and tissues, suggest that these reference 179 genes should also function well for virus-infected body parts or tissues, but this should be 180 
